Bloom Energy Work in process decreased by 15.7% to $105.46M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 19.7%, from $88.11M to $105.46M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 33.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $45.14M | $40.82M | $31.89M | $41.35M | $40.72M | $37.36M | $44.66M | $55.01M | $55.94M | $53.86M | $50.63M | $71.14M | $85.91M | $105.21M | $79.60M | $88.11M | $89.68M | $110.49M | $125.04M | $105.46M |
| QoQ Change | — | -9.6% | -21.9% | +29.6% | -1.5% | -8.3% | +19.6% | +23.2% | +1.7% | -3.7% | -6.0% | +40.5% | +20.8% | +22.5% | -24.3% | +10.7% | +1.8% | +23.2% | +13.2% | -15.7% |
| YoY Change | — | — | — | — | -9.8% | -8.5% | +40.0% | +33.0% | +37.4% | +44.2% | +13.4% | +29.3% | +53.6% | +95.4% | +57.2% | +23.9% | +4.4% | +5.0% | +57.1% | +19.7% |
| % of Inventories | 27.6% | 22.4% | 22.2% | 22.6% | 19.7% | 14.7% | 16.6% | 13.8% | 11.9% | 11.3% | 10.1% | 13.5% | 16.5% | 18.0% | 14.6% | 14.4% | 13.0% | 15.7% | 19.4% | 14.4% |
| Share Change | — | -5.3pp | -0.1pp | +0.3pp | -2.9pp | -5.0pp | +2.0pp | -2.8pp | -1.9pp | -0.6pp | -1.2pp | +3.4pp | +3.0pp | +1.5pp | -3.4pp | -0.2pp | -1.4pp | +2.7pp | +3.8pp | -5.0pp |